Nature Reviews Nephrology (2018) 10.1038/s41581-018-0077-4415 Published online 03 December 2018
In the key to Figure 1 of this article, ‘Amyloid microtubules’ has been corrected to ‘Microtubules’.
. 2018 Dec 19;15(2):121. doi: 10.1038/s41581-018-0102-7
Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
Nelson Leung
1,✉, Frank Bridoux
2, Vecihi Batuman
3, Aristeidis Chaidos
4, Paul Cockwell
5, Vivette D D’Agati
6, Angela Dispenzieri
1, Fernando C Fervenza
1, Jean- Paul Fermand
7, Simon Gibbs
8, Julian D Gillmore
9, Guillermo A Herrera
10, Arnaud Jaccard
11, Dragan Jevremovic
1, Efstathios Kastritis
12, Vishal Kukreti
13, Robert A Kyle
1, Helen J Lachmann
9, Christopher P Larsen
14, Heinz Ludwig
15, Glen S Markowitz
6, Giampaolo Merlini
16, Peter Mollee
17, Maria M Picken
18, Vincent S Rajkumar
1, Virginie Royal
19, Paul W Sanders
20, Sanjeev Sethi
1, Christopher P Venner
21, Peter M Voorhees
22, Ashutosh D Wechalekar
9, Brendan M Weiss
23, Samih H Nasr
1
Nelson Leung
1Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN USA
Find articles by Nelson Leung
Frank Bridoux
2Department of Nephrology, Centre Hospitalier Universitaire et Université de Poitiers, Poitiers, France; CNRS UMR7276, Limoges, France; and Centre de Référence Amylose AL et Autres Maladies par Dépôt d’Immunoglobulines Monoclonales, Poitiers, France
Find articles by Frank Bridoux
Vecihi Batuman
3Veterans Administration Medical Center, New Orleans, LA, USA and Tulane University Medical School, Tulane, LA USA
Find articles by Vecihi Batuman
Aristeidis Chaidos
4Centre for Haematology, Department of Medicine, Imperial College London and Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK
Find articles by Aristeidis Chaidos
Paul Cockwell
5Department of Nephrology, Renal Medicine — University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK
Find articles by Paul Cockwell
Vivette D D’Agati
6Department of Pathology, Renal Pathology Laboratory, Columbia University, College of Physicians and Surgeons, New York, NY USA
Find articles by Vivette D D’Agati
Angela Dispenzieri
1Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN USA
Find articles by Angela Dispenzieri
Fernando C Fervenza
1Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN USA
Find articles by Fernando C Fervenza
Jean- Paul Fermand
7Department of Haematology and Immunology, University Hospital St Louis, Paris, France
Find articles by Jean- Paul Fermand
Simon Gibbs
8The Victorian and Tasmanian Amyloidosis Service, Department of Haematology, Monash Univerity Easter Health Clinical School, Melbourne, Victoria, Australia
Find articles by Simon Gibbs
Julian D Gillmore
9National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, London, UK
Find articles by Julian D Gillmore
Guillermo A Herrera
10Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center, Shreveport, LA USA
Find articles by Guillermo A Herrera
Arnaud Jaccard
11Service d’Hématologie et de Thérapie Cellulaire, Centre de Référence des Amyloses Primitives et des Autres Maladies par Dépôts d’Immunoglobuline, CHU Limoges, Limoges, France
Find articles by Arnaud Jaccard
Dragan Jevremovic
1Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN USA
Find articles by Dragan Jevremovic
Efstathios Kastritis
12Department of Clinical Therapeutics, School of Medicine National and Kapodistrian University of Athens Alexandra Hospital, Athens, Greece
Find articles by Efstathios Kastritis
Vishal Kukreti
13University Health Network, Princess Margaret Cancer Centre, Toronto, Canada
Find articles by Vishal Kukreti
Robert A Kyle
1Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN USA
Find articles by Robert A Kyle
Helen J Lachmann
9National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, London, UK
Find articles by Helen J Lachmann
Christopher P Larsen
14Arkana Laboratories, Little Rock, AR USA
Find articles by Christopher P Larsen
Heinz Ludwig
15Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria
Find articles by Heinz Ludwig
Glen S Markowitz
6Department of Pathology, Renal Pathology Laboratory, Columbia University, College of Physicians and Surgeons, New York, NY USA
Find articles by Glen S Markowitz
Giampaolo Merlini
16Amyloidosis Research and Treatment Center, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
Find articles by Giampaolo Merlini
Peter Mollee
17Haematology Department, Princess Alexandra Hospital and School of Medicine, University of Queensland, Brisbane, Australia
Find articles by Peter Mollee
Maria M Picken
18Department of Pathology, Loyola University Medical Center, Maywood, IL USA
Find articles by Maria M Picken
Vincent S Rajkumar
1Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN USA
Find articles by Vincent S Rajkumar
Virginie Royal
19Department of Pathology, Hôpital Maisonneuve- Rosemont, Université de Montreal, Montreal, Quebec Canada
Find articles by Virginie Royal
Paul W Sanders
20Department of Medicine, University of Alabama at Birmingham and Department of Veterans Affairs Medical Center, Birmingham, AL USA
Find articles by Paul W Sanders
Sanjeev Sethi
1Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN USA
Find articles by Sanjeev Sethi
Christopher P Venner
21Cross Cancer Institute, University of Alberta, Edmonton, Alberta Canada
Find articles by Christopher P Venner
Peter M Voorhees
22Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium System, Charlotte, NC USA
Find articles by Peter M Voorhees
Ashutosh D Wechalekar
9National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, London, UK
Find articles by Ashutosh D Wechalekar
Brendan M Weiss
23Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA USA
Find articles by Brendan M Weiss
Samih H Nasr
1Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN USA
Find articles by Samih H Nasr
1Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN USA
2Department of Nephrology, Centre Hospitalier Universitaire et Université de Poitiers, Poitiers, France; CNRS UMR7276, Limoges, France; and Centre de Référence Amylose AL et Autres Maladies par Dépôt d’Immunoglobulines Monoclonales, Poitiers, France
3Veterans Administration Medical Center, New Orleans, LA, USA and Tulane University Medical School, Tulane, LA USA
4Centre for Haematology, Department of Medicine, Imperial College London and Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK
5Department of Nephrology, Renal Medicine — University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK
6Department of Pathology, Renal Pathology Laboratory, Columbia University, College of Physicians and Surgeons, New York, NY USA
7Department of Haematology and Immunology, University Hospital St Louis, Paris, France
8The Victorian and Tasmanian Amyloidosis Service, Department of Haematology, Monash Univerity Easter Health Clinical School, Melbourne, Victoria, Australia
9National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, London, UK
10Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center, Shreveport, LA USA
11Service d’Hématologie et de Thérapie Cellulaire, Centre de Référence des Amyloses Primitives et des Autres Maladies par Dépôts d’Immunoglobuline, CHU Limoges, Limoges, France
12Department of Clinical Therapeutics, School of Medicine National and Kapodistrian University of Athens Alexandra Hospital, Athens, Greece
13University Health Network, Princess Margaret Cancer Centre, Toronto, Canada
14Arkana Laboratories, Little Rock, AR USA
15Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria
16Amyloidosis Research and Treatment Center, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
17Haematology Department, Princess Alexandra Hospital and School of Medicine, University of Queensland, Brisbane, Australia
18Department of Pathology, Loyola University Medical Center, Maywood, IL USA
19Department of Pathology, Hôpital Maisonneuve- Rosemont, Université de Montreal, Montreal, Quebec Canada
20Department of Medicine, University of Alabama at Birmingham and Department of Veterans Affairs Medical Center, Birmingham, AL USA
21Cross Cancer Institute, University of Alberta, Edmonton, Alberta Canada
22Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium System, Charlotte, NC USA
23Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA USA
✉
Corresponding author.
Issue date 2019.
© Springer Nature Limited 2018
This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
PMCID: PMC7608309 PMID: 30568288
This corrects the article "The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group" on page 45.